EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidental Detection of PSMA-Avid Thymic Squamous Cell Carcinoma on [68Ga]Ga-PSMA-11 PET/CT During Initial Prostate Cancer Staging

Choon-Young Kim iD, Shin Young Jeong

Diagnostics · 03.11.2026 · 16 (21) · 3637

DOI: 10.3390/diagnostics16213637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 03.11.2026. Verfasst von Choon-Young Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu 41944, Republic of K…. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A man in his 70s with biopsy-confirmed prostate adenocarcinoma underwent gallium-68-labeled prostate-specific membrane antigen (PSMA)-11 ([68Ga]Ga-PSMA-11) positron emission tomography/computed tomography (PET/CT) for initial staging. In addition to intense PSMA uptake in the prostate (maximum standardized uptake value [SUVmax], 15.3), PET/CT incidentally revealed a moderately PSMA-avid anterior mediastinal mass (SUVmax, 6.1). Contrast-enhanced chest CT showed a 6.4 cm heterogeneously enhancing anterior mediastinal mass suspicious for an invasive thymic malignancy, with possible invasion of the adjacent lung and pericardium. Multiple left pleural nodules raised concern for pleural metastases. The patient underwent total thymectomy, lung wedge resection, pericardial excision, and pleural nodule biopsies. Histopathology confirmed moderately differentiated thymic squamous cell carcinoma with lung and pericardial invasion and pleural metastasis (pT2N0M1a, TNM stage IVA; Masaoka–Koga stage IVa). Tumor-cell positivity for p40, CD5, CD117 (c-kit), and GLUT1, together with the histopathological and anatomical findings, supported the diagnosis. The patient subsequently completed four cycles of cisplatin, doxorubicin, and cyclophosphamide chemotherapy, with stable disease in the response assessment, while the concurrent prostate cancer was managed with androgen deprivation therapy. This case illustrates the importance of CT morphology and tissue confirmation when an atypically located PSMA-avid lesion is encountered during prostate cancer staging.

Schlagwörter

Stichwörter der Autor:innen

[68Ga]Ga-PSMA-11 PET/CTprostate cancerprostate-specific membrane antigenthymic squamous cell carcinoma

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
  • Department of Nuclear Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu 41404, Republic of Korea.

ORCID-Profile: Choon-Young Kim

Zitieren

APA

Kim, C. Y., & Jeong, S. Y. (2026). Incidental Detection of PSMA-Avid Thymic Squamous Cell Carcinoma on [68Ga]Ga-PSMA-11 PET/CT During Initial Prostate Cancer Staging. Diagnostics, 16(21), 3637. https://doi.org/10.3390/diagnostics16213637

Vancouver

Kim CY, Jeong SY. Incidental Detection of PSMA-Avid Thymic Squamous Cell Carcinoma on [68Ga]Ga-PSMA-11 PET/CT During Initial Prostate Cancer Staging. Diagnostics. 2026;16(21):3637. doi:10.3390/diagnostics16213637

BibTeX
@article{Kim2026,
  author = {Kim, Choon-Young and Jeong, Shin Young},
  title = {Incidental Detection of PSMA-Avid Thymic Squamous Cell Carcinoma on [68Ga]Ga-PSMA-11 PET/CT During Initial Prostate Cancer Staging},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {21},
  pages = {3637},
  doi = {10.3390/diagnostics16213637}
}
Kostenlos starten →